{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:08:54Z","timestamp":1782479334942,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"China National Natural Science Funds","doi-asserted-by":"crossref","award":["81330003, 31571170"],"award-info":[{"award-number":["81330003, 31571170"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"China National Natural Science Funds","doi-asserted-by":"crossref","award":["81630009"],"award-info":[{"award-number":["81630009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"China National Natural Science Funds","doi-asserted-by":"crossref","award":["81700350"],"award-info":[{"award-number":["81700350"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Talents Innovation and Entrepreneurship Projects","award":["2015R019"],"award-info":[{"award-number":["2015R019"]}]},{"name":"Chang Jiang Scholar Program","award":["T2011160"],"award-info":[{"award-number":["T2011160"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.bbrc.2018.09.100","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T05:56:31Z","timestamp":1537595791000},"page":"317-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Administration of ubiquitin-activating enzyme UBA1 inhibitor PYR-41 attenuates angiotensin II-induced cardiac remodeling in mice"],"prefix":"10.1016","volume":"505","author":[{"given":"Qing","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Lian","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.09.100_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCHEARTFAILURE.114.001785","article-title":"Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy","volume":"8","author":"von Lueder","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.bbrc.2018.09.100_bib2","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.hrthm.2015.12.048","article-title":"Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy","volume":"13","author":"Maron","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.bbrc.2018.09.100_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1253\/circj.CJ-16-0062","article-title":"From left ventricular hypertrophy to dysfunction and failure","volume":"80","author":"Lazzeroni","year":"2016","journal-title":"Circ. J."},{"key":"10.1016\/j.bbrc.2018.09.100_bib4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell. Mol. Life Sci. : CMLS"},{"key":"10.1016\/j.bbrc.2018.09.100_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCRESAHA.114.300507","article-title":"Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure","volume":"114","author":"Oka","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2018.09.100_bib6","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.febslet.2005.01.068","article-title":"The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy","volume":"579","author":"Tanaka","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2018.09.100_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCRESAHA.109.208801","article-title":"Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease","volume":"106","author":"Willis","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2018.09.100_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd3321","article-title":"Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets","volume":"10","author":"Bedford","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2018.09.100_bib9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.molmed.2015.08.003","article-title":"UBA1: at the crossroads of ubiquitin homeostasis and neurodegeneration","volume":"21","author":"Groen","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbrc.2018.09.100_bib10","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.4161\/cc.19978","article-title":"Ubiquitin-activating enzyme UBA1 is required for cellular response to DNA damage","volume":"11","author":"Moudry","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbrc.2018.09.100_bib11","doi-asserted-by":"crossref","first-page":"e1000131","DOI":"10.1371\/journal.pgen.1000131","article-title":"E1 ubiquitin-activating enzyme UBA-1 plays multiple roles throughoutC. elegansdevelopment","volume":"4","author":"Kulkarni M","year":"2008","journal-title":"PLoS genet."},{"key":"10.1016\/j.bbrc.2018.09.100_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.nmd.2013.02.001","article-title":"Clinical and neuropathological features of X-linked spinal muscular atrophy (SMAX2) associated with a novel mutation in the UBA1 gene","volume":"23","author":"Dlamini","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbrc.2018.09.100_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/j.1460-2075.1991.tb07940.x","article-title":"Varshavsky, UBA 1: an essential yeast gene encoding ubiquitin-activating enzyme","volume":"10","author":"McGrath JP","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2018.09.100_bib14","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.2174\/1381612811319180004","article-title":"Targeting the ubiquitin E1 as a novel anti-cancer strategy","volume":"19","author":"Xu","year":"2013","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.bbrc.2018.09.100_bib15","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1161\/CIRCULATIONAHA.115.020754","article-title":"Genetic and pharmacologic inhibition of the chemokine receptor CXCR2 prevents experimental hypertension and vascular dysfunction","volume":"134","author":"Wang","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2018.09.100_bib16","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/eurheartj\/ehy085","article-title":"CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration","volume":"39","author":"Wang","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrc.2018.09.100_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yexmp.2016.01.001","article-title":"High concentrations of H2O2 trigger hypertrophic cascade and phosphatase and tensin homologue (PTEN) glutathionylation in H9c2 cardiomyocytes","volume":"100","author":"Panera","year":"2016","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbrc.2018.09.100_bib18","article-title":"Regulation of myocardial fibrosis by MicroRNAs","volume":"56","author":"Bauersachs","year":"2010","journal-title":"J.\u00a0Cardiovasc. Pharmacol. J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.09.100_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.atherosclerosis.2010.07.061","article-title":"PTEN differentially regulates expressions of ICAM-1 and VCAM-1 through PI3K\/Akt\/GSK-3beta\/GATA-6 signaling pathways in TNF-alpha-activated human endothelial cells","volume":"213","author":"Tsoyi","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2018.09.100_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/10799893.2012.695798","article-title":"PTEN regulation of ERK1\/2 signaling in cancer","volume":"32","author":"Chetram","year":"2012","journal-title":"J.\u00a0Recept. Signal Transduct. Res."},{"key":"10.1016\/j.bbrc.2018.09.100_bib21","doi-asserted-by":"crossref","first-page":"e112082","DOI":"10.1371\/journal.pone.0112082","article-title":"Structural model of the hUbA1-UbcH10 quaternary complex: in silico and experimental analysis of the protein-protein interactions between E1, E2 and ubiquitin","volume":"9","author":"Correale","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2018.09.100_bib22","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1182\/blood-2009-07-231191","article-title":"The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma","volume":"115","author":"Xu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2018.09.100_bib23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/imm.12255","article-title":"Ubiquitin-activating enzyme E1 inhibitor PYR41 attenuates angiotensin II-induced activation of dendritic cells via the IkappaBa\/NF-kappaB and MKP1\/ERK\/STAT1 pathways","volume":"142","author":"Chen","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.bbrc.2018.09.100_bib24","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/SHK.0000000000000931","article-title":"PYR-41, a ubiquitin-activating enzyme E1 inhibitor, attenuates lung injury in sepsis","volume":"49","author":"Matsuo","year":"2018","journal-title":"Shock"},{"key":"10.1016\/j.bbrc.2018.09.100_bib25","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.1158\/0008-5472.CAN-07-0568","article-title":"Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics","volume":"67","author":"Yang","year":"2007","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2018.09.100_bib26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.atherosclerosis.2016.02.016","article-title":"The ubiquitin-activating enzyme E1 as a novel therapeutic target for the treatment of restenosis","volume":"247","author":"Qin","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2018.09.100_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.HYP.0000153321.13792.b9","article-title":"Angiotensin II and the endothelium: diverse signals and effects","volume":"45","author":"Watanabe","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2018.09.100_bib28","article-title":"Angiotensin 1-7 suppresses Angiotensin II mediated aldosterone production via JAK\/STAT signaling inhibition","author":"Itcho","year":"2018","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbrc.2018.09.100_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yjmcc.2018.07.243","article-title":"Network-based predictions of in\u00a0vivo cardiac hypertrophy","volume":"121","author":"Frank","year":"2018","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2018.09.100_bib30","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1074\/jbc.M116.773085","article-title":"Transforming growth factor-beta (TGF-beta) directly activates the JAK1-STAT3 Axis to induce hepatic fibrosis in coordination with the SMAD pathway","volume":"292","author":"Tang","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.09.100_bib31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000489757","article-title":"Cardiac ablation of SOCS3 aggravates DOCA-salt-induced hypertrophic remodeling by activation of gp130-dependent signaling in mice","volume":"47","author":"Liu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbrc.2018.09.100_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-kappaB: a key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2018.09.100_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.HYP.0000254415.31362.a7","article-title":"Role of oxidative stress in cardiac hypertrophy and remodeling","volume":"49","author":"Takimoto","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2018.09.100_bib34","doi-asserted-by":"crossref","first-page":"35786","DOI":"10.1074\/jbc.M102479200","article-title":"The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival","volume":"276","author":"Schwartzbauer","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.09.100_bib35","doi-asserted-by":"crossref","first-page":"28258","DOI":"10.1074\/jbc.M303318200","article-title":"Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells","volume":"278","author":"Wu","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.09.100_bib36","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/HYPERTENSIONAHA.117.10390","article-title":"Novel role for the immunoproteasome subunit PSMB10 in angiotensin II-induced atrial fibrillation in mice","volume":"71","author":"Li","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2018.09.100_bib37","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/1087057111433843","article-title":"Identification and mechanistic studies of a novel ubiquitin E1 inhibitor","volume":"17","author":"Ungermannova","year":"2012","journal-title":"J.\u00a0Biomol. Screen"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18320278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18320278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T04:02:40Z","timestamp":1543636960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18320278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0006291X18320278"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.09.100","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Administration of ubiquitin-activating enzyme UBA1 inhibitor PYR-41 attenuates angiotensin II-induced cardiac remodeling in mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.09.100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}